©The Author(s) 2025.
World J Transplant. Dec 18, 2025; 15(4): 104349
Published online Dec 18, 2025. doi: 10.5500/wjt.v15.i4.104349
Published online Dec 18, 2025. doi: 10.5500/wjt.v15.i4.104349
Table 11 Ongoing clinical trials
| NCT number | Title | Condition | Actual enrolment | Recruitment status | Location | Age of participants |
| NCT03765203 | Utility of a novel dd-cfDNA test to detect injury in renal post-transplant patients | Kidney transplant failure | 175 participants | Completed | United States | Child, adult, older adult |
| NCT04271267 | Cell-free DNA as a biomarker after lung transplantation | Lung transplant recipients | 125 participants | Completed | No data | Adult, older adult |
| NCT02424227 | Non invasive blood test to diagnose acute rejection after kidney transplantation | Kidney transplant recipients | 401 participants | Active, not recruiting | United States | Child, adult |
| NCT01985412 | Non-invasive sequencing-based diagnosis of rejection | Cardiac transplant rejection; lung transplant rejection | 65 participants | Completed | United States | Child, adult |
| NCT02109575 | Quantitative detection of circulating donor specific DNA in organ transplant recipients | Cardiovascular disease; acute rejection of cardiac transplant; cardiac transplant rejection; heart transplant failure and rejection | No data | Active, not recruiting | United States | Child, adult, older adult |
- Citation: Salvadori M, Rosso G. Utility and limitations of the use of donor-derived cell-free DNA in kidney transplantation. World J Transplant 2025; 15(4): 104349
- URL: https://www.wjgnet.com/2220-3230/full/v15/i4/104349.htm
- DOI: https://dx.doi.org/10.5500/wjt.v15.i4.104349